These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19062597)

  • 1. [Temporary hyperosmolar breakage of the blood-brain barrier improves effectiveness of chemotherapy for cerebral tumors].
    Aronov MS; Kobiakov GL; Lubnin AIu; Iakovlev SB
    Zh Vopr Neirokhir Im N N Burdenko; 2008; (3):52-9. PubMed ID: 19062597
    [No Abstract]   [Full Text] [Related]  

  • 2. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow.
    Hiesiger EM; Voorhies RM; Basler GA; Lipschutz LE; Posner JB; Shapiro WR
    Ann Neurol; 1986 Jan; 19(1):50-9. PubMed ID: 3080944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opening of blood-brain barrier in Triturus cristatus carnifex by hyperosmolar mannitol solutions.
    Franceschini V; Ciani F; Lazzari M; Del Grande P; Minelli G
    Basic Appl Histochem; 1988; 32(3):327-32. PubMed ID: 3147653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier disruption in the treatment of brain tumors.
    Blanchette M; Fortin D
    Methods Mol Biol; 2011; 686():447-63. PubMed ID: 21082387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-tumor barrier disruption controversies.
    Blasberg RG; Groothuis DR
    J Cereb Blood Flow Metab; 1991 Jan; 11(1):165-8. PubMed ID: 1898507
    [No Abstract]   [Full Text] [Related]  

  • 6. The blood-brain barrier disruption controversy: does it hold water?
    Ruffer JE; Glatstein E
    Cancer J Sci Am; 1998; 4(2):84-5. PubMed ID: 9532409
    [No Abstract]   [Full Text] [Related]  

  • 7. Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors.
    Neuwelt EA; Hill SA; Frenkel EP; Diehl JT; Maravilla KR; Vu LH; Clark WK; Rapoport SI; Barnett PA; Lewis SE; Ehle AL; Beyer CW
    Cancer Treat Rep; 1981; 65 Suppl 2():39-43. PubMed ID: 6809316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin.
    Brown RC; Egleton RD; Davis TP
    Brain Res; 2004 Jul; 1014(1-2):221-7. PubMed ID: 15213006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review).
    van Vulpen M; Kal HB; Taphoorn MJ; El-Sharouni SY
    Oncol Rep; 2002; 9(4):683-8. PubMed ID: 12066192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?
    Kemper EM; Boogerd W; Thuis I; Beijnen JH; van Tellingen O
    Cancer Treat Rev; 2004 Aug; 30(5):415-23. PubMed ID: 15245774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-brain barrier and chemotherapeutic treatment of brain tumors.
    de Vries NA; Beijnen JH; Boogerd W; van Tellingen O
    Expert Rev Neurother; 2006 Aug; 6(8):1199-209. PubMed ID: 16893347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain-barrier disruption interventional neuroradiology in brain tumor therapy.
    Heimberger K; Samec P; Binder H; Horaczek A; Mutz N
    Ann Radiol (Paris); 1986; 29(2):230-2. PubMed ID: 3090924
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy and the treatment of brain metastases.
    Peak S; Abrey LE
    Hematol Oncol Clin North Am; 2006 Dec; 20(6):1287-95. PubMed ID: 17113463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic effects of an osmotic bolus for the reversible opening of the blood-brain barrier].
    Hiesmayr M; Dirnberger H; Aloy A; Heimberger K; Horaczek A; Brandstätter B; Zimpfer M
    Schweiz Med Wochenschr; 1987 Mar; 117(12):450-4. PubMed ID: 3107120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery to brain tumours: challenges and progress.
    Ningaraj NS
    Expert Opin Drug Deliv; 2006 Jul; 3(4):499-509. PubMed ID: 16822225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy in brain tumors].
    van den Bent MJ; Schellens JH; Sillevis Smitt PA; Vecht CJ
    Ned Tijdschr Geneeskd; 1996 Mar; 140(13):702-6. PubMed ID: 8668248
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacodynamics and the blood-brain barrier.
    Blasberg RG
    Natl Cancer Inst Monogr; 1977 Dec; 46():19-27. PubMed ID: 349396
    [No Abstract]   [Full Text] [Related]  

  • 18. Chapter 11 - Solid lipid nanoparticles for brain tumors therapy: State of the art and novel challenges.
    Brioschi AM; Calderoni S; Zara GP; Priano L; Gasco MR; Mauro A
    Prog Brain Res; 2009; 180():193-223. PubMed ID: 20302836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy of malignant brain tumors: biology and pharmacokinetics (author's transl)].
    Hoshino T
    No Shinkei Geka; 1980 Nov; 8(11):1007-16. PubMed ID: 7005704
    [No Abstract]   [Full Text] [Related]  

  • 20. Is there a therapeutic role for osmotic breaching of the blood-brain barrier?
    Fishman RA
    Ann Neurol; 1987 Sep; 22(3):298-9. PubMed ID: 3118761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.